Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Cerner (CERN) To Report Q1 Earnings: What's In The Offing?

Published 04/21/2019, 10:17 PM
Updated 07/09/2023, 06:31 AM
CAH
-
CERN
-
MDSO_old
-
NVTAQ
-

Cerner Corporation’s (NASDAQ:CERN) first-quarter 2019 results are scheduled to release on Apr 25. In the last reported quarter, the company’s earnings were in-line with the Zacks Consensus Estimate. Further, it has an average four-quarter positive surprise of 0.83%.

Let’s take a look at how things are shaping up prior to this announcement.

Which Way Are Q1 Estimates Treading?

The Zacks Consensus Estimate for first-quarter earnings is pegged at 61 cents, suggesting an improvement of 5.2% from the year-ago quarter. The same for revenues is pegged at $1.39 billion, indicating a rise of 7.5% from the year-ago reported figure.

Bookings to Decline in Q1

Management at Cerner expects bookings revenues between $1.1 billion and $1.3 billion in the first quarter. The mid-point of this range reflects a 14% decrease compared with the company’s much higher-than-normal level of large long-term bookings in the prior-year quarter. The Zacks Consensus Estimate for first quarter bookings is pegged at $1.32 billion, indicating a decline of 5.7% from the year-ago quarter. Notably, softness in bookings might impact the company’s revenue growth.

However, the company anticipates witnessing bookings growth in 2019, in terms of long-term bookings, on the back of several large, long-term deals that are in the pipeline in this time period.

Factors to Influence Q1

In the first quarter, the company is expected to witness top-line growth, backed by the anticipated increase in revenues across professional as well as managed services segments, and support and maintenance business line. Notably, the company expects revenues to range between $1.37 billion and $1.42 billion in the first quarter. The midpoint of this range reflects growth of 8% from the year-ago quarter.

Given the structural and process changes that are being made by the company, Cerner is likely to become more focused and efficient, which in turn might increase predictability and profitability. In fact, adjusted earnings per share are expected in the band of 60-62 cents. The mid-point of this range is 5% higher than the year-ago quarter.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Cerner Corporation Price and EPS Surprise

Cerner Corporation Price and EPS Surprise | Cerner Corporation Quote

Further, strong contributions from the key areas, namely Population Health, Revenue Cycle and IT Works are likely to drive the company’s overall performance. Moreover, better-than-expected non-U.S. revenues are likely to have contributed to the overall results in the to-be-reported quarter.

However, the company is likely to have experienced contraction in gross and operating margins in the first quarter primarily owing to headwinds like non-cash software amortization and depreciation, traditional software revenue growth challenges.

Here’s What the Quantitative Model Predicts:

Our proven Zacks model clearly shows that a company with a solid Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has good chances of beating estimates if it also has a positive Earnings ESP. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Cerner has a Zacks Rank #2 and an Earnings ESP of +1.05%, the combination makes us reasonably confident of an earnings beat.

Please note that we caution against stocks with a Zacks Rank #4 or 5 (Sell rated) going into the earnings announcement, especially when the company is seeing negative estimate revisions.

Other Stocks Worth a Look

Here are a few other stocks worth considering from the broader medical space as these too have the right combination of elements to beat on earnings this time around.

Medidata Solutions, Inc. (NASDAQ:MDSO) has an Earnings ESP of +12.31% and a Zacks Rank #3.

Invitae Corporation (NYSE:NVTA) has an Earnings ESP of +2.84% and a Zacks Rank #3.

Cardinal Health, Inc. (NYSE:CAH) has an Earnings ESP of +1.13% and a Zacks Rank #3.You can see the complete list of today’s Zacks #1 Rank stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Is Your Investment Advisor Fumbling Your Financial Future?

See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”

Click to get it free >>



Invitae Corporation (NVTA): Free Stock Analysis Report

Medidata Solutions, Inc. (MDSO): Free Stock Analysis Report

Cerner Corporation (CERN): Free Stock Analysis Report

Cardinal Health, Inc. (CAH): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.